⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3141227 | 0.71 | — | — | |
| SCHEMBL937165 | 0.69 | ALDH1A1 (0.33) | — | |
| SCHEMBL90415 | 0.69 | — | — | |
| SCHEMBL1276314 | 0.69 | — | — | |
| SCHEMBL17729823 | 0.69 | — | — | |
| SCHEMBL6033248 | 0.69 | — | — | |
| SCHEMBL516538 | 0.69 | MAPK1 (0.33) | — | |
| SCHEMBL6307992 | 0.67 | — | — | |
| SCHEMBL2257571 | 0.67 | — | — | |
| Ammonia Solution, Strong SCHEMBL16412132 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210206758-A1 | NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2021-07-08 | — | — | US | claimed |
| EP-3433254-B1 | NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2020-06-17 | — | — | EP | claimed |
| US-20190112306-A1 | NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2019-04-18 | — | — | US | claimed |
| EP-3433254-A1 | NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2019-01-30 | — | — | EP | claimed |
| WO-2017162570-A1 | NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-09-28 | — | — | WO | claimed |
| US-20050081787-A1 | Apparatus and method for supplying a source, and method of depositing an atomic layer using the same | IM KI-VIN (KR) | 2005-04-21 | — | — | US | claimed |
| US-20230420248-A1 | METHOD OF DEPOSITING ATOMIC LAYER AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-12-28 | — | — | US | disclosed |
| US-20230348438-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2023-11-02 | — | — | US | disclosed |
| EP-3366808-B1 | METHOD OF FORMING LAYERS ON A SUBSTRATE | UNIV WAYNE STATE (US) | 2023-10-25 | — | — | EP | disclosed |
| US-20230197509-A1 | WET FUNCTIONALIZATION OF DIELECTRIC SURFACES | LAM RESEARCH CORPORATION | 2023-06-22 | — | — | US | disclosed |
| CN-116234784-A | Method of manufacturing an environmental barrier | 赛峰集团陶瓷 | 2023-06-06 | — | — | CN | disclosed |
| CN-115769362-A | Wet functionalization of dielectric surfaces | 朗姆研究公司 | 2023-03-07 | — | — | CN | disclosed |
| WO-2021236886-A1 | WET FUNCTIONALIZATION OF DIELECTRIC SURFACES | LAM RESEARCH CORPORATION (US) | 2021-11-25 | — | — | WO | disclosed |
| EP-0145434-A2 | Novel dihydropyridine derivatives and process for preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1985-06-19 | — | — | EP | disclosed |
| US-4504659-A | 1-Oxadethiacepham compounds | SHIONOGI & CO., LTD. (JP) | 1985-03-12 | — | — | US | disclosed |
| EP-0132676-A2 | Phosphoric or phosphonic acid esters | BAYER AG (DE) | 1985-02-13 | — | — | EP | disclosed |
| US-4478997-A | 1-Oxadethiacepham compounds | SHIONOGI & CO., LTD. (JP) | 1984-10-23 | — | — | US | disclosed |
| US-4443598-A | ANTIBIOTICS AND INTERMEDIATES | SHIONOGI & CO., LTD. (JP) | 1984-04-17 | — | — | US | disclosed |
| EP-0100476-A2 | Phosphoric-acid esters, process for their preparation and their use as pesticides | BAYER AG (DE) | 1984-02-15 | — | — | EP | disclosed |
| US-4366316-A | FROM OXAZOLINOAZETIDINONE AND ACID | SHIONOGI & CO., LTD. (JP) | 1982-12-28 | — | — | US | disclosed |